XKLS
HARTA
Market cap960mUSD
Apr 24, Last price
1.15MYR
Name
Hartalega Holdings Berhad
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hartalega Holdings Berhad operates as an investment holding enterprise with a primary focus on the global manufacturing, distribution, and sale of latex and nitrile gloves. Its extensive market reach spans Malaysia, North America, Europe, various regions of Asia, Australia, South America, and the Middle East. Additionally, the company diversifies its operations through property leasing, pioneering research and development in automation systems, and the international export and trade of medical supplies. Its product offerings cater to a wide array of industries, including healthcare, dentistry, food processing, industrial use, veterinary care, and the spa and beauty salon sectors. The company was established in 1988 and maintains its headquarters in Kuala Lumpur, Malaysia.
Key people
Kam Hon Kuan
Executive Chairman of the Board · since 2012
Wah Choon Leang
General Manager - MIS · since 2015
Tian Chai Low
General Manager, Quality Assurance · since 2018
Teck Heng Tan
General Manager - Finance · since 2016
Hoong Ton Wong
General Manager - Manufacturing · since 2016
Danaraj Nadarajah
Non-Independent Executive Director · since 2011
Mun Keng Kuan
Non-Independent Executive Director, Sales and Marketing Director · since 2008
Kim Lui Ng
General Manager - Sales and Marketing · since 2017
Vin Seung Kuan
Director of Human Resources · since 2009
Eu Jin Kuan
Director of Research & Development and Technical · since 2008
Swee Ang Ng
Director of Manufacturing · since 2016
Muhammad Hakimi Tan Bin Abdullah
Director of Manufacturing · since 2012
Joint Company Secretary · since 2012
Joint Company Secretary · since 2009
Razman Hafidz bin Abu Zarim
Independent Non-Executive Director · since 2015
Non-Executive Independent Director · since 2016
Took Gee Loo
Independent Non-Executive Director · since 2019
Non-Executive Independent Director · since 2011
Valuation
Title MYR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||